Homburger advises Santhera on the First Exchange Offer for a Convertible Bond in Switzerland and Issuance of New Senior Unsecured Convertible Bonds due 2024

On May 4, 2021, Santhera Pharmaceuticals Holding AG (SIX: SANN) announced the settlement of the first exchange offer for a convertible bond in Switzerland. Holders of Santhera’s existing CHF 60 m Senior Unsecured Convertible Bonds due 2022 received one new CHF 30,270,375 Senior Unsecured Convertible Bond due 2024 and 26 Santhera shares per existing bond. The offer had been accepted by holders of 74.7% of the former bonds.

Homburger acted as transaction counsel in this matter. The team was led by partners Dieter Gericke and Daniel Häusermann (both Corporate / M&A, Capital Markets). Key members of the team included partner Stefan Oesterhelt (Tax), counsel Eduard De Zordi (Financing and Investment Products) and associates Marco Rostetter and Romain Fakhoury (both Corporate / M&A, Capital Markets), as well as Pierina Janett-Seiler and Daniel Junginger (both Financing and Investment Products) and junior associate Daniel Bötticher.